Published in Cancer Weekly, September 26th, 2000
The use of Taxol (paclitaxel) plus Paraplatin (carboplatin), administered in a novel weekly regimen, offers a safe and effective treatment option for patients with advanced lung cancer, according to research presented September 13, 2000, at the 9th World Conference on Lung Cancer, held in Tokyo, Japan. Safety and tolerability are of critical importance in patients with advanced lung cancer.
"These data show that the use of weekly Taxol plus Paraplatin provides a very tolerable treatment for patients with advanced lung cancer," reported Chandra...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.